You are required to be logged in to access the full website
Click here if you have forgotten your username or password
27 May 2026 - Rare disease pharmacy solutions provider Orsini announced on Tuesday that it is the contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod) 8.5 mg, a subcutaneous injection for the treatment of chronic hepatitis del...
27 May 2026 - ILC Dover, an Ingersoll Rand business involved in design and production for biopharmaceutical, pharmaceutical, and medical device markets, announced on Tuesday that it recently invested in two new core capabilities: Water for Injection ...
27 May 2026 - CordenPharma, a Switzerland-based global Contract Development and Manufacturing Organisation (CDMO), announced on Wednesday that it has entered into an agreement to acquire AmbioPharm, a US-headquartered peptide Active Pharmaceutical In...
26 May 2026 - Neurology specialist Merz Therapeutics GmbH and its Chinese partner Jiangxi Kvvit Pharmaceutical Co Ltd on Tuesday announced an exclusive licence and collaboration agreement for INBRIJA (levodopa inhalation powder) and its proprietary i...
26 May 2026 - Swedish pharmaceutical company OncoZenge AB (Nasdaq First North Growth Market:ONCOZ) announced on Tuesday that it has received European regulatory approval to initiate its pivotal Phase III BEAM-Pain trial of BupiZenge (BZ003) for oral ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe